3
Clinical Trials associated with ABO-1108 / Active, not recruitingPhase 2 A Randomized, Blinded and Placebo-Control Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
The primary objective of this study is to evaluate the immunogenicity and safety of 2 injections (approximately 2 months apart) of ABO1108 in adults aged 40 years or above.
/ Active, not recruitingPhase 1 评价在40岁及以上受试者中接种冻干带状疱疹mRNA疫苗的安全性和免疫原性的随机、盲法、对照的Ⅰ期临床试验
[Translation] A randomized, blinded, controlled phase I clinical trial to evaluate the safety and immunogenicity of a freeze-dried herpes zoster mRNA vaccine in subjects aged 40 years and above
[Translation] Primary objective: To evaluate the safety of the investigational vaccine after 2 doses
/ Active, not recruitingPhase 1 A Randomized, Blinded and Positive-Control Phase I Clinical Trial to Evaluate the Immunogenicity and Safety of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
The primary objective of this study is to evaluate the tolerability, reactogenicity and safety of 2 injections (approximately 2 months apart) of three different dose levels of ABO1108 in adults aged 40 years or above.
100 Clinical Results associated with ABO-1108
100 Translational Medicine associated with ABO-1108
100 Patents (Medical) associated with ABO-1108
100 Deals associated with ABO-1108